Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV vaccination and changes in detection of these lesions due to updated cervical cancer screening and management recommendations, the Centers for Disease Control and Prevention reported today. Screen-detected, high-grade cervical lesions develop within a few years after infection and have been used to monitor HPV vaccine impact because HPV-associated cancers typically take decades to develop. In 2006, HPV vaccine was licensed and recommended for girls aged 11-12 and for catch-up vaccination through age 26.

Related News Articles

Headline
AdventHealth’s Be a Mindleader initiative aims to help children and parents become more comfortable discussing mental health and connect families to counseling…
Headline
Access to quality mental and physical health services can be a complex challenge, but for individuals of color and people with severe or chronic mental…
Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…
Blog
EnglISH¿Qué pasa si una conversación puede cambiar, o incluso salvar, una vida? Esa fue la pregunta que AdventHealth buscó responder, cuando el sistema de…
Blog
ESPAÑOLWhat if one conversation can change, or even save, a life? That was the question AdventHealth sought to answer, as the health system launched a…
Headline
The AHA July 11 released its quarterly Health Care Plan Accountability Update, a roundup of news, letters, statements and other resources covering private…